Northrop Grumman heads into its October 20 earnings with the stock at a fresh multi-month low and options traders hedging more aggressively than at any point in the past year.
The clearest signal is in options. The put/call ratio hit 1.29 on Monday — essentially matching the 52-week high of 1.29 set just the day before — and closed the week at 1.23. That reading runs almost 1.7 standard deviations above the 20-day average of 1.15, a level of defensive positioning that has not been seen all year. Against a stock down 4% on the week and 7.5% over the past month to $509.86, the options market is telling a story of investors reaching for downside protection rather than fading the dip.
Short interest, by contrast, tells a much calmer story. Bears hold just 1.7% of the free float — a genuinely low level — and that number has been falling, not rising, with shares short down roughly 0.3% on the week. The borrow market is essentially frictionless: availability is near maximum, with 95 million shares available to lend against a short position of just 2.4 million. Cost to borrow has risen sharply in percentage terms, up 59% on the week to 0.43%, but from an extremely low base — this is cheap stock to short by any measure. The ORTEX short score of 31.4 ranks in the 66th percentile, confirming there is no short-squeeze pressure lurking here. Overall, positioning looks cautious rather than crowded: options traders are hedging into earnings, while the short book is modest and the lending market wide open.
The Street debate centres on one word: B-21. Bernstein cut its target to $620 from $653 on Tuesday — the most recent move, and notable given the name — citing continued concern about fixed-price loss exposure on the bomber program. That sits alongside a Guggenheim initiation at Buy with a $612 target last week, and a UBS target raise to $704 earlier this month. The average target across the analyst community is $645, implying roughly 26% upside from current levels, and the consensus remains Buy. But the divergence between bullish targets and the stock's 8% year-to-date decline tells its own story. The bear case is specific: B-21 cost overruns, Space Systems headwinds from program realignments, and any further softening in government contract flow. The bull case rests on the B-21 eventually turning the corner, a one-third international backlog providing revenue diversity, and the Sentinel ICBM program as a long-duration growth anchor. Valuation has re-rated lower alongside the price — the P/E multiple has compressed by roughly 1.4 turns over the past 30 days to around 17x, while EV/EBITDA has eased to 13.1x.
Institutional flows add an interesting wrinkle. BlackRock added around 900,000 shares in the most recent reported period, a meaningful increase. T. Rowe Price added over 1.2 million shares. Both moves were filed as of August 31, so they reflect buying that predates some of the recent weakness. On the activist register, The Vanguard Group filed a 13G/A in March showing its stake had dropped to zero from 9.16% previously — a notable exit, though as always with 13D/G disclosures, the timing and pace of the reduction are not fully visible from the filing alone. A separate Vanguard Capital Management entity subsequently filed a fresh 13G showing a 7.22% stake, and Capital International Investors trimmed from 5.2% to 4.3% as of August. The net picture is one of passive index mechanics at work rather than any activist agenda, with no 13D filers on the register.
The October 20 print is the event that matters most. In the three most recent earnings releases, NOC moved modestly on the day — the July 2026 result produced a 3.2% gain on the day, though the stock faded over the following week. The question heading into Q3 results is less about revenue and more about whether management provides any updated guidance on B-21 program costs, and whether Space Systems shows signs of stabilising after a difficult stretch. With the put/call ratio at a 52-week peak and the stock near its weakest level of the year, the setup into that release warrants watching closely.
See the live data behind this article on ORTEX.
Open NOC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
